Scholarlink

Purpose <p>Pruritus is a common and distressing symptom among dialysis patients, yet its underlying mechanisms remain incompletely understood. Most previous research has focused on systemic inflammatory markers, while little is known about local skin alterations contributing to pruritus. This study aimed to characterize skin biomarker profiles in dialysis patients with pruritus, in comparison with dialysis patients without pruritus and healthy controls, and to explore differences between pruritic and non-pruritic skin sites.</p> Methods <p>In this multi-center cross-sectional exploratory study, stratum corneum samples were obtained using the tape-stripping method from 91 participants (67 dialysis patients and 24 healthy controls). Biomarkers were quantified, and adjusted linear and logistic (mixed) models were used to assess group differences and skin site variations.</p> Results <p>Dialysis patients with pruritus exhibited a significantly elevated IL-1RA/IL-1<i>α</i> ratio and reduced IL-18 levels compared to non-pruritic patients. There was also a strong indication of concomitant increases in IL-1RA and IFN-<i>β</i> in pruritic skin. Across all dialysis patients, IL-8, CCL17, and CXCL10 levels were significantly lower than in healthy controls, independent of pruritus status.</p> Conclusion <p>Dialysis patients with pruritus demonstrate distinct alterations in skin immune profiles suggestive of localized inflammation and potential involvement of the opioid pathway. These findings provide new insights into the inflammatory mechanisms underlying pruritus in this population and may inform the development of targeted, personalized therapies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Exploring novel skin biomarkers related to pruritus in dialysis patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月9日

查看全文
  • Thomas S. van Lieshout,
  • Shannah Bennett,
  • Jop Vreeken,
  • Sanja Kezic,
  • Patrick M. J. H. Kemperman,
  • Rosalie M. Luiten,
  • Edwin M. Spithoven,
  • Erik L. Penne,
  • Thomas Rustemeyer,
  • Brigit C. van Jaarsveld,
  • Alferso C. Abrahams

摘要

Purpose

Pruritus is a common and distressing symptom among dialysis patients, yet its underlying mechanisms remain incompletely understood. Most previous research has focused on systemic inflammatory markers, while little is known about local skin alterations contributing to pruritus. This study aimed to characterize skin biomarker profiles in dialysis patients with pruritus, in comparison with dialysis patients without pruritus and healthy controls, and to explore differences between pruritic and non-pruritic skin sites.

Methods

In this multi-center cross-sectional exploratory study, stratum corneum samples were obtained using the tape-stripping method from 91 participants (67 dialysis patients and 24 healthy controls). Biomarkers were quantified, and adjusted linear and logistic (mixed) models were used to assess group differences and skin site variations.

Results

Dialysis patients with pruritus exhibited a significantly elevated IL-1RA/IL-1α ratio and reduced IL-18 levels compared to non-pruritic patients. There was also a strong indication of concomitant increases in IL-1RA and IFN-β in pruritic skin. Across all dialysis patients, IL-8, CCL17, and CXCL10 levels were significantly lower than in healthy controls, independent of pruritus status.

Conclusion

Dialysis patients with pruritus demonstrate distinct alterations in skin immune profiles suggestive of localized inflammation and potential involvement of the opioid pathway. These findings provide new insights into the inflammatory mechanisms underlying pruritus in this population and may inform the development of targeted, personalized therapies.